Showing results (511-520 of 518) with videos related to
Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 518 results.
Molecular Cancer|August 31, 2017
The oncogenic role of the In1-ghrelin splicing variant in prostate cancer aggressivenessDaniel Hormaechea-Agulla, Manuel D Gahete, Juan M Jiménez-Vacas, et al.Cell Metabolism|December 2, 2008
Identification of adropin as a secreted factor linking dietary macronutrient intake with energy homeostasis and lipid metabolismK Ganesh Kumar, James L Trevaskis, Daniel D Lam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 19, 2019
A Somatostatin Receptor Subtype-3 (SST<sub>3</sub>) Peptide Agonist Shows Antitumor Effects in Experimental Models of Nonfunctioning Pituitary TumorsMari C Vázquez-Borrego, Vandana Gupta, Alejandro Ibáñez-Costa, et al.Scientific Reports|February 10, 2017
BIM-23A760 influences key functional endpoints in pituitary adenomas and normal pituitaries: molecular mechanisms underlying the differential response in adenomasAlejandro Ibáñez-Costa, Laura M López-Sánchez, Manuel D Gahete, et al.Transfusion|February 9, 2020
Variations in hemoglobin measurement and eligibility criteria across blood donation services are associated with differing low-hemoglobin deferral rates: a BEST Collaborative studySaurabh Zalpuri, Bas Romeijn, Elias Allara, et al.Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|October 26, 2005
PYY3-36 as an anti-obesity drug targetM M Boggiano, P C Chandler, K D Oswald, et al.Blood Cancer Journal|November 4, 2022
GATA-3 is a proto-oncogene in T-cell lymphoproliferative neoplasmsXiangrong Geng, Chenguang Wang, Xin Gao, et al.Nature|July 13, 2004
Physiology: does gut hormone PYY3-36 decrease food intake in rodents?M Tschöp, T R Castañeda, H G Joost, et al.Pageof 52